Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 40,858 shares at $103.27 ($4.1M) on 2025-11-17, disclosed to the SEC on 2025-11-19.
Scheduled sale ($4.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.80 | 3,609 | $339K | 8.3% |
| 2 | $93.80 | 3,609 | $339K | 8.3% |
| 3 | $95.12 | 3,266 | $311K | 7.6% |
| 4 | $95.12 | 3,266 | $311K | 7.6% |
| 5 | $100.58 | 4,496 | $452K | 11.1% |
| 6 | $100.58 | 4,496 |
| $452K |
| 11.1% |
| 7 | $102.13 | 3,194 | $326K | 8.0% |
| 8 | $102.13 | 3,194 | $326K | 8.0% |
| 9 | $103.27 | 5,055 | $522K | 12.8% |
| 10 | $103.27 | 5,055 | $522K | 12.8% |
| 11 | $103.68 | 380 | $39K | 1.0% |
| 12 | $103.61 | 220 | $23K | 0.6% |
| 13 | $104.54 | 509 | $53K | 1.3% |
| 14 | $104.54 | 509 | $53K | 1.3% |
| Total | $99.56 avg | 40,858 | $4.1M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |